Tonix Pharmaceuticals Holding Corp. (TNXP) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Track Tonix Pharmaceuticals Holding Corp. (TNXP) stock performance with short-term forecasts for 2025 and long-term TNXP price prediction till 2050. Review historical trends, get analyst Buy/Sell/Hold ratings, and stay updated with the latest Tonix Pharmaceuticals Holding Corp. headlines.
1 Month Prediction
$2.33 [508.15%]
3 Month Prediction
$1.00 [161.03%]
6 Month Prediction
$1.00 [161.03%]
1 Year Prediction
$1.00 [161.03%]
3 Year Prediction
$1.00 [161.03%]
5 Year Prediction
$1.00 [161.03%]
About Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company that develops therapies for central nervous system disorders, immunology conditions, infectious diseases, and rare diseases.
Tonix's lead product candidate is TNX-102 SL, a sublingual tablet that contains cyclobenzaprine, for the management of fibromyalgia and acute stress disorder.
Also, Tonix Pharma also develops TNX-1300 for treating cocaine intoxication and TNX-2900 for Prader-Willi syndrome, a rare genetic disorder. The company also works on immunology therapies, such as TNX-1500, which targets organ transplant rejection and autoimmune diseases.
Tonix Pharmaceuticals Holding Corp. (TNXP) Historical Performance
Change
Since inception, TNXP has decreased by 100.00%. In the last 5 years, TNXP has fallen from $6912.00 to $0.38, a massive -99.99% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $8256.00 and a low of $0.15.
52 Week Range
$0.12
$12.48
The current price $0.38 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
TNXP Stock Price History
Based on TNXP stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the TNXP stock has fallen from $3584.0 - $8960.0 to $0.38 - $0.38, which is down -100.0%. Currently, the stock follows downward trend.
Here, we have calculated stock range of TNXP, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $3584.0 - $8960.0 | $5328.0 | -91.95 | 1 Year Change |
| 2021 | $2304.0 - $8192.0 | $5488.0 | -91.71 | 2 Year Change |
| 2022 | $78.0 - $1536.0 | $568.0 | -99.14 | 3 Year Change |
| 2023 | $12.8 - $224.0 | $68.75 | -99.9 | 4 Year Change |
| 2024 | $0.15 - $12.16 | $3.47 | -99.99 | 5 Year Change |
| 2025 | $0.38 - $0.38 | $0.38 | -100.0 | 6 Year Change |
TNXP Price Performance
6-Month Performance
TNXP stock jumped by 66.57% in the last six months.
1-Year Performance
The stock has trended downwards by 96.85% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 99.97%.
5-Year Performance
In the last 5 years, the stock has gone down by 99.99%.
According to Tonix Pharmaceuticals Holding Corp.'s historical data, below graph gives us the exact picture of how the TNXP stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 0 year and a decline in 5 years.
2020
41.88% ↓
2021
47.06% ↓
2022
96.61% ↓
2023
83.59% ↓
2024
97.42% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Tonix Pharmaceuticals Holding Corp. (TNXP) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $2.82 M (Q3)
Revenue for Q3 ending 30th September, 2024 increased 27.81% compared to Q2 ending 30th June, 2024.
Annual Revenue: $11.29 M (1Y)
Revenue for trailing 12 months increased 45.35% year over year from 31st December, 2023.
If compared to the last 5 years, the revenue has gone up from $0.00 to $11.29 million, a 1,129,099,999,900.00% change.
Market Capitalization
Tonix Pharmaceuticals Holding Corp. has a market capitalization of $71.60M, which places TNXP in the micro-cap category.
Fundamental Analysis
EPS: $-0.23 (Q3), $-219.20 (1Y)
EPS decreased 98.81% since last quarter, and decreased 66.48% since last year.
Net Income: $-14.21 M (Q3), $-116.66 M (1Y)
Net Income decreased 81.96% since last quarter, and increased 5.84% since last year.
Free Cash Flow: $-18.81 M (Q3), $-109.90 M (1Y)
Free Cash Flow increased 89.64% since last quarter, and decreased 24.83% since last year.
Net Profit Margin: -503.65% (Q3), -1033.19% (1Y)
Net Profit Margin decreased 85.88% since last quarter, and decreased 27.18% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for TNXP stock. These indicators help you understand Tonix Pharmaceuticals Holding Corp.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for TNXP stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $0.30 |
| SMA50 | $0.26 |
| SMA200 | $1.46 |
| RSI | 62.96 |
| Beta | 2.08 |
SMA20 < Current Price
This signals TNXP stock is in short-term bullish momentum.
SMA50 < Current Price
This signals TNXP stock is in mid-term bullish momentum.
SMA200 > Current Price
This signals TNXP stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for TNXP stock is Neutral. Out of all indicators, 3 indicates bullish signals, 3 signals bearish trends and 3 gives neutral trends. The TNXP stock forecast was last updated on 26 January, 2025.
Tonix Pharmaceuticals Holding Corp. (TNXP) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $1.00 by the end of 2025, and can reach around $1.24 to $1.24 in 2026. And, the long-term forecast suggests that the stock may further jump to $0.59 - $0.84 in 2028, and $0.71 - $0.34 by 2031. So, the TNXP stock shows a strong upward trend in the next several years.
Short-term TNXP Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-02 | $2.33 | 508.2% |
| 2025-03 | $1.00 | 161.03% |
| 2025-04 | $1.00 | 161.03% |
| 2025-05 | $1.00 | 161.03% |
| 2025-06 | $1.00 | 161.03% |
| 2025-07 | $1.00 | 161.03% |
| 2025-08 | $1.00 | 161.03% |
| 2025-09 | $1.00 | 161.03% |
| 2025-10 | $1.00 | 161.03% |
| 2025-11 | $1.00 | 161.03% |
| 2025-12 | $1.00 | 161.03% |
In 2025, the TNXP stock price is expected to fluctuate between $1.0 and $2.33. According to the monthly forecast, the stock could rise to $1.00 by December 2024. If compared to the TNXP's current price, the stock could gain 161.03% by the end of this year.
Long-term TNXP Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $1.24 | $1.74 | $1.24 | 223.68% |
| 2027 | $0.30 | $0.78 | $1.20 | 213.23% |
| 2028 | $0.59 | $1.14 | $0.84 | 119.26% |
| 2029 | $0.83 | $1.02 | $1.66 | 333.31% |
| 2030 | $0.96 | $1.13 | $0.62 | 61.84% |
| 2031 | $0.71 | $1.24 | $0.34 | -11.25% |
| 2032 | $1.55 | $0.93 | $1.24 | 223.68% |
| 2033 | $0.59 | $0.80 | $0.62 | 61.84% |
| 2034 | $0.61 | $1.05 | $1.50 | 291.54% |
| 2035 | $1.39 | $0.83 | $0.88 | 129.71% |
| 2036 | $1.23 | $1.08 | $0.56 | 46.18% |
| 2037 | $0.88 | $0.52 | $0.61 | 59.23% |
| 2038 | $0.60 | $0.78 | $0.95 | 147.98% |
| 2039 | $0.94 | $0.68 | $0.52 | 35.73% |
| 2040 | $0.54 | $1.53 | $1.07 | 179.3% |
| 2041 | $0.57 | $1.43 | $1.11 | 189.74% |
| 2042 | $0.64 | $1.32 | $0.51 | 33.12% |
| 2043 | $1.18 | $0.55 | $0.73 | 90.55% |
| 2044 | $1.49 | $0.93 | $0.94 | 145.37% |
| 2045 | $0.88 | $0.86 | $1.20 | 213.23% |
| 2046 | $1.13 | $1.31 | $0.74 | 93.16% |
| 2047 | $1.10 | $1.34 | $1.03 | 168.86% |
| 2048 | $0.70 | $1.56 | $1.12 | 192.35% |
| 2049 | $1.22 | $0.70 | $0.89 | 132.32% |
| 2050 | $1.00 | $1.05 | $1.02 | 166.25% |
| 2051 | $1.04 | $1.04 | $1.86 | 385.51% |
Tonix Pharmaceuticals Holding Corp. (TNXP) Stock Price Prediction & Forecast 2025
At the start of 2025, the TNXP stock was at $0.38. Today, it is trading at $0.38, which is 0.00% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $1.00 by December 2025 with a 161.03% change.
Tonix Pharmaceuticals Holding Corp. (TNXP) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the TNXP stock. During this period, the TNXP's price is forecasted to shift from $1.24 to $0.62, which is -50.00% loss.
In 2026, the stock would possibly open at $1.24, escalates to $1.74 by mid-year, and wraps up at $1.24, reflecting a 222.63% increase from today's price. Further moving to 2030, the stock can kick off the year at $0.96, soar to $1.13 by mid-year, and finish at $0.62, which is 61.83% change from current price.
Tonix Pharmaceuticals Holding Corp. (TNXP) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $0.71 to $1.07, which is up -10.27%
In 2031, we can expect TNXP to fluctuate between $0.34 and $0.71, a shift indicating a -10.27% loss by year-end compared to current price. And Until 2040, TNXP can likely vary from $0.54 to $1.07. By the end of 2040, the stock could record a 179.29% rise from today's stock price.
Tonix Pharmaceuticals Holding Corp. (TNXP) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the TNXP stock can see an an upturn from $0.57 to $1.02 in this period. In 2041, the stock can experience a high of $1.43 by mid-year, closing the year at $1.11. This results in a 273.11% increase from today.
Moving towards the end of 2050, TNXP is projected to open the year at $1.00. The stock may peak to $1.05 during mid-year and finish the year at $1.02. Compared to the stock's current price, this translates to an overall gain of 166.59% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
TNXP Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| OCGN | Ocugen, Inc. | - | $0.78 | -3.11% ▼ | $275.15 ▲ |
| MRNA | Moderna, Inc. | - | $42.25 | 1.61% ▲ | $304.87 ▲ |
| IPA | ImmunoPrecise Antibodies Ltd. | - | $0.53 | 28.28% ▲ | $117.56 ▲ |
| NVAX | Novavax, Inc. | - | $9.31 | 15.86% ▲ | $74.57 ▲ |
| HOTH | Hoth Therapeutics, Inc. | - | $1.24 | 65.78% ▲ | $32.95 ▲ |
Last updated Jan 26 at 7:29 PM
TNXP : Buy, Sell Or Hold?
Analyst Ratings
Based on 1 analysts, 0 rated as a strong buy, 1 recommended a buy, 0 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.So, according to analyst ratings, the recommendation for TNXP stock is Buy.
Expert Analysis
According to TNXP short-term and long-term forecast, Tonix Pharmaceuticals Holding Corp. shares are projected to go up by 166.25%, and reach a value of $1.02 per share by 2050.
As per technical analysis, indicators show a Neutral sentiment, while Fear & Greed Index stands at 21.428571428571427, which signals Fear. Also, TNXP has recorded 6/30 green days, which reflects a 31.57894736842105% positivity rate with a price volatility of 0.28%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that TNXP stock is undervalued. So, Based on TNXP prediction and analysis, it may be the best time to hold TNXP stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "TNXP” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.